hotspot -WSS

hotspot

author：explore 2025-09-30 14:34:16 - browse：9369

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

focus

WSS

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

How to keep neuroscience’s past racism from being its future

Readout Newsletter: Bluebird, CVS, Contineum

App could help diagnose ear infections more accurately — and at home

David Ricks of Eli Lilly: best biopharma CEO of 2023

Medicare Advantage beneficiaries sue Humana over algorithm use

hotspot

hotspot

Wikipedia

Drug repurposing or repositioning? The language matters

Neuroscience’s long legacy of racism

Tori Bowie and the unacceptable rates of Black maternal death

Plastic surgeons increase patient psychiatric screenings

Medicare details structure of new drug price negotiation program

HCA sued by state AG for quality issues at Mission Health

Medical leaders decry Supreme Court decision on affirmative action

Baby aspirin cuts fat buildup in liver disease patients, in small study

Continuity nursing helped my family in our darkest PICU moments

In Spain, a hospital brews its own CAR

leisure time

Readout Newsletter: Bluebird, CVS, Contineum

Why health records don't always know when patients are dead

Baby aspirin cuts fat buildup in liver disease patients, in small study

In Spain, a hospital brews its own CAR

Future doctors should be trained to promote social change

Virtual care provider acquires bankrupt Pear's prescription apps

knowledge

focus

focus

hotspot